TNON
Income statement / Annual
Last year (2024), Tenon Medical, Inc.'s total revenue was $3.28 M,
an increase of 11.92% from the previous year.
In 2024, Tenon Medical, Inc.'s net income was -$13.67 M.
See Tenon Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$3.28 M |
$2.93 M |
$691.00 K |
$160.00 K |
$43.82 K |
$53.64 K |
| Cost of Revenue |
$1.57 M
|
$1.69 M
|
$1.33 M
|
$55.00 K
|
$18.26 K
|
$18.26 K
|
| Gross Profit |
$1.71 M
|
$1.24 M
|
-$641.00 K
|
$105.00 K
|
$25.56 K
|
$35.38 K
|
| Gross Profit Ratio |
0.52
|
0.42
|
-0.93
|
0.66
|
0.58
|
0.66
|
| Research and Development Expenses |
$2.60 M
|
$3.16 M
|
$2.83 M
|
$1.72 M
|
$220.88 K
|
$371.55 K
|
| General & Administrative Expenses |
$7.77 M
|
$7.03 M
|
$7.42 M
|
$2.71 M
|
$311.67 K
|
$171.66 K
|
| Selling & Marketing Expenses |
$5.11 M
|
$6.78 M
|
$7.83 M
|
$2.14 M
|
$29.30 K
|
$25.62 K
|
| Selling, General & Administrative Expenses |
$12.87 M
|
$13.81 M
|
$15.26 M
|
$4.85 M
|
$340.97 K
|
$197.28 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$15.48 M
|
$16.97 M
|
$18.08 M
|
$6.57 M
|
$561.85 K
|
$568.83 K
|
| Cost And Expenses |
$17.04 M
|
$18.66 M
|
$19.42 M
|
$6.62 M
|
$580.11 K
|
$587.08 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$52.36 K
|
| Interest Expense |
$34.00 K
|
$21.00 K
|
$354.00 K
|
$621.00 K
|
$167.85 K
|
$52.36 K
|
| Depreciation & Amortization |
$655.00 K
|
$426.00 K
|
$289.00 K
|
$114.00 K
|
$0.00
|
$533.44 K
|
| EBITDA |
-$12.98 M |
-$15.13 M |
-$18.27 M |
-$6.35 M |
-$537.52 K |
-$30.00 |
| EBITDA Ratio |
-3.96
|
-5.17
|
-26.45
|
-39.66
|
-12.27
|
-0
|
| Operating Income Ratio |
-4.2
|
-5.37
|
-27.1
|
-40.38
|
-12.24
|
-9.94
|
| Total Other Income/Expenses Net |
$93.00 K
|
$146.00 K
|
-$192.00 K
|
-$620.00 K
|
-$169.08 K
|
-$52.39 K
|
| Income Before Tax |
-$13.67 M
|
-$15.58 M
|
-$18.92 M
|
-$7.08 M
|
-$705.37 K
|
-$585.83 K
|
| Income Before Tax Ratio |
-4.17
|
-5.32
|
-27.38
|
-44.26
|
-16.1
|
-10.92
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$13.67 M
|
-$15.58 M
|
-$18.92 M
|
-$7.05 M
|
-$585.18 K
|
-$509.58 K
|
| Net Income Ratio |
-4.17
|
-5.32
|
-27.38
|
-44.05
|
-13.35
|
-9.5
|
| EPS |
-11.26 |
-68.64 |
-187.3 |
-624.38 |
-56.4 |
-49.12 |
| EPS Diluted |
-11.26 |
-68.64 |
-187.3 |
-624.38 |
-56.4 |
-49.12 |
| Weighted Average Shares Out |
$1.21 M
|
$227.00 K
|
$101.00 K
|
$11.29 K
|
$10.38 K
|
$10.38 K
|
| Weighted Average Shares Out Diluted |
$1.21 M
|
$227.00 K
|
$101.00 K
|
$11.29 K
|
$10.38 K
|
$10.38 K
|
| Link |
|
|
|
|
|
|
